Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

David C Tully

4PUBLICATIONS

7CO-AUTHORS

Innate immunityMedical virologyMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Dec 19, 2025

Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.

Vincent H J Leonard, Dianna B Vidales, Benjamin R Taft

|Jul 23, 2025

Discovery and Optimization of a Novel Series of Influenza A Virus Replication Inhibitors Targeting the Nucleoprotein Protein-Protein Interaction.

Benjamin R Taft, Matthew J Hesse, Mulugeta Mamo

|Jan 16, 2020

Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis.

Donatella Chianelli, Paul V Rucker, Jason Roland

|Nov 18, 2017

Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).

David C Tully, Paul V Rucker, Donatella Chianelli

Pageof 1

Frequent Collaborators

2 joint publications

Benjamin R Taft

2 joint publications

Kelly A Wong

1 joint publications

Phil B Alper

1 joint publications

Valentina Molteni

1 joint publications

Matthew J Hesse

1 joint publications

Johanna R Abend

1 joint publications

Don Ganem

Frequent Collaborators

2 joint publications

Benjamin R Taft

2 joint publications

Kelly A Wong

1 joint publications

Phil B Alper

1 joint publications

Valentina Molteni

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells

Published on : Jun 03, 2012

Novel <em>In Vivo</em> Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel <em>In Vivo</em> Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on : Mar 24, 2023

See more related videos

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells

Published on : Jun 03, 2012

Novel <em>In Vivo</em> Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel <em>In Vivo</em> Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on : Mar 24, 2023

See more related videos